Pharmaceutical

Avacta Group files patent for extended circulating seru...

Discover Avacta Group's groundbreaking patent for therapeutic conjugates with ex...

CTS Europe: The roadmap for generative AI in the pharma...

AI remained one of the main talking points at CTS Europe, as the roadmap for gen...

Citius aims to bounce back from Lymphir setback

Citius Pharmaceuticals’ CEO detailed plans to launch its lymphoma therapy Lymphi...

Sionna raises $182m to double down in cystic fibrosis d...

Sionna could have four candidates in clinical trials in 2024, amidst a cystic fi...

Merck reports drop in net income for fiscal 2023

Merck has reported a 15.1% decline in net income attributable to shareholders to...

Microplastics found in blood vessels linked to greater ...

Microplastics found in blood vessels are linked to a greater risk of heart probl...

Biden to propose expanding Medicare drug price negotiat...

President Biden wants to more than double the size of Medicare’s new drug price ...

STAT+: Senate panel advances bill to ban some Chinese b...

A Senate panel passed a bill aimed at preventing some Chinese biotechs from doin...

Opinion: The CDC’s new, relaxed Covid isolation guidanc...

The CDC’s new Covid isolation guidance reflects the best way to approach public ...

Bayer’s not breaking up. At least not yet

Will Bayer respond to long-time pressures to separate its drug and agricultural ...

STAT+: Pharmalittle: We’re reading about HIV drug resis...

The World Health Organization said resistance to GSK's HIV drug dolutegravir has...

STAT+: Startup Alumis raises $259 million as it prepare...

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big p...

STAT+: With Meta’s backing, Headspace launches into VR

Headspace XR, developed with funding from Meta, guides users through meditation ...

Florida health officials provide scant details on measl...

Health experts are expressing concern about a dearth of information about the me...

STAT+: Republicans consider a new attack on Biden ‘marc...

Biden has taken aim at drug patents with a "march-in" rights idea. Republicans a...

STAT+: Oracle Health chair says Cerner isn’t competing ...

Cerner's new owner aims to win customers with cloud services instead of just ele...